Loading…
← CockpitCompetitor Analysis › 002173.SZ Innovation Medical Management Co., Ltd. Class AOpen in the cockpit ↗

Innovation Medical Management Co., Ltd. Class A002173.SZCompetitor analysis, valuation and peers

China · CNY·Industrials›Wholesale Distributors

Chinese hospital-management and healthcare-services group operating a network of private hospitals.

Momentum weak 24
Mkt cap
$980M
US dollars, full cap
Free float
76%
of shares outstanding
$/day
$70.7M
20-day average traded
Fwd P/E
n/m
no positive forecast
ROIC−WACC
-11.5 pp
WACC 8.9%
Hurdle
n/a
no reverse DCF
Close · CNYCN¥15.36
1D-3.1%
1W-13.6%
1M-6.8%
3M-30.4%
6M-34.2%
YTD-28.6%
1Y-36.5%
ATR %6.0%
52w lowhigh59.9% off high

What Innovation Medical Management does

Chinese hospital-management and healthcare-services group operating a network of private hospitals.

Products and services

  • Hospital operation/management
  • Medical device distribution (legacy)

Customers

  • Patients
  • Local health authorities

Where it sits in the supply chain

  • Health Care
  • Healthcare services
  • Private hospital operation

What could go right

  • Private healthcare demand growth

What could go wrong

  • Regulatory/insurance reimbursement risk

Moat: narrow (regulatory licence, scale). Hospital operating licences and an existing multi-hospital network create local barriers to entry.

Headquarters: China · Employees: 2,572

Named competitors

Innovation Medical Management at a glance

Size Innovation Medical Management (002173.SZ) is a China Industrials company (Wholesale Distributors) with a market value of $980M, the 2193rd largest of 4,790 China companies the cockpit tracks. Shares closed at CN¥15.36 on 18 Nov 2026.

Performance Over six months the shares fell 34.2%, against -20.9% for the median peer and -20.0% for the China market (cap-weighted) — 6th lowest of 21 in its peer set.

Growth Revenue fell 13.3% over the last twelve months (peer median +15.6%); the operating margin is -17.9% (peer median 6.0%).

Valuation It trades at 8.9× enterprise value to sales against a peer median of 0.9× (most expensive of 20).

Capital Return on invested capital runs 11.5 points below its cost of capital (8.9% WACC).

Relative performance

8010021 May 202621 Aug 202618 Nov 2026Peer median 80002173.SZ 67
Six months, rebased to 100: Innovation Medical Management against the median of its 20 peers (local-currency closes).

Innovation Medical Management financials

Reported figures in CNY; fiscal year ends 2025-12-31. TTM = trailing twelve months.
TTMFY2025FY2024FY2023FY2022
RevenueCN¥696MCN¥781MCN¥816MCN¥805MCN¥710M
Revenue growth—-4%+1%+13%—
Gross profitCN¥69.2MCN¥40.9MCN¥49.1MCN¥74.2MCN¥11.5M
EBITDAn/aCN¥39.1MCN¥45.0MCN¥75.7MCN¥30.6M
Net income-CN¥121M-CN¥34.9M-CN¥94.0M-CN¥34.3M-CN¥73.4M
Free cash flow-CN¥57.8M-CN¥8.59M-CN¥53.9M-CN¥85.2M-CN¥130M
Capital expenditureCN¥47.8MCN¥84.5MCN¥47.0MCN¥96.2MCN¥123M
Total debtCN¥85.6MCN¥82.3MCN¥77.2MCN¥68.5MCN¥60.2M

Quarterly statements and history in the cockpit →

Innovation Medical Management competitor charts

The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.

Performance: 6-month against 1-month return

-60%-40%-20%0%+20%-20%-10%0%60108625908051APR9830BYW600313SNL6010260990001120002993813160501198829960IMD3008936038093010002173.SZ6-month return →1-month return →
Up and to the right = strong over both horizons. Innovation Medical Management is the large dot.

Fundamentals: revenue growth against valuation

0%+50%+100%0×5×60108625908051APR9830600313SNL60102609900029936050119960IMD300893002173.SZRevenue growth (TTM) →EV / Sales →
Further right = faster growth; higher = more expensive. The dashed lines are the peer medians. Innovation Medical Management is the large dot.

Innovation Medical Management competitors and peer comparison

Head to head with its named competitors (002173.SZ vs 300015.SZ vs 1515.HK)
CompanyMarket cap6M returnRevenue growthOp. marginEV / SalesReq g
Innovation Medical Management 002173.SZ$980M-34%-13%-18%8.9×n/a
Aier Eye Hospital 300015.SZ$12.5B-14%+5%21%3.7×11.8%
China Resources Medical 1515.HK$393M-10%0%6%0.4×-7.5%

How Innovation Medical Management compares with its peers

Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.

Innovation Medical Management against its 20 peers (data as of 18 Nov 2026)
Measure002173.SZPeer medianRank in peer set
1-month return-6.8%-6.6%11th highest of 21
6-month return-34.2%-20.9%6th lowest of 21
Distance from 52-week high-59.9%-38.1%4th lowest of 21
Revenue growth (TTM)-13.3%+15.6%lowest of 20
Operating margin-17.9%6.0%lowest of 20
EV / Sales8.9×0.9×most expensive of 20
ROIC minus cost of capital-11.5 pp+1.5 pp2nd lowest of 20

Peer table

Peer set: Industry: the same industry and sector in any market, nearest in size
CompanyMarketMarket cap6M returnRevenue growthOp. marginEV / SalesReq gDelivered g
Innovation Medical Management 002173.SZChina$980M-34%-13%-18%8.9×n/an/a
Gansu Guofang Industry & Trade (Group) 601086.SSChina$980M+17%+16%7%6.9×11.5%-4.8%
Beijing Geekplus Technology 2590.HKHong Kong$964M-65%+33%0%1.3×n/an/a
Yamazen 8051.TJapan$1.00B+4%+12%3%0.2×-7.7%+4.5%
Auto Partner APR.WAPoland$958M+13%+67%8%0.6×-4.0%+21.5%
Trusco Nakayama 9830.TJapan$1.01B+9%+10%7%0.6×n/an/a
BayWa BYW.DEGermany$1.01B-61%n/an/an/an/an/a
China Agricultural Development Seed 600313.SSChina$944M-18%+35%1%0.8×19.9%+12.7%
Supply Network SNL.AXAustralia$1.03B+20%+16%17%3.9×11.7%+19.9%
Techstorm Advanced Material 601026.SSChina$1.05B-41%+8%6%2.2×n/an/a
Deep Source 0990.HKHong Kong$906M-32%+7%2%0.2×-15.7%+6.1%
Lx International 001120.KSSouth Korea$906M-25%+11%2%0.2×-6.2%+8.2%
Dongguan Aohai Technology 002993.SZChina$1.06B-55%+122%1%0.6×n/an/a
Mitsuuroko 8131.TJapan$901M+37%+4%3%0.4×-0.6%+8.4%
Hangzhou Cogeneration 605011.SSChina$900M-32%-1%5%2.1×n/an/a
Yellow Hat 9882.TJapan$897M+6%+7%9%0.9×-5.5%+3.1%
Totech 9960.TJapan$1.07B+2%+4%11%0.9×5.4%+9.2%
Imdex IMD.AXAustralia$1.08B-24%+21%16%3.6×19.6%+14.5%
Zhejiang Songyuan Automotive Safety Systems 300893.SZChina$1.09B-39%+27%12%2.9×n/an/a
Chengdu Haoneng Technology 603809.SSChina$1.09B-30%+18%10%3.5×n/an/a
Wah Lee Industrial 3010.TWTaiwan$878M-12%+16%4%0.4×-6.7%+5.8%

Questions

Who are Innovation Medical Management's main competitors?
Named competitors: Aier Eye Hospital Group (300015.SZ), Phoenix Healthcare Group (1515.HK). The cockpit's measured peer set (industry) also includes Gansu Guofang Industry & Trade (Group) (601086.SS), Beijing Geekplus Technology (2590.HK), Yamazen (8051.T), Auto Partner (APR.WA), Trusco Nakayama (9830.T), BayWa (BYW.DE).
Is Innovation Medical Management expensive compared with its peers?
On ev / sales it trades at 8.9× against a peer median of 0.9×, most expensive of 20 in its peer set.
How has Innovation Medical Management stock performed?
Over six months to 18 Nov 2026 the shares returned -34.2% against -20.9% for the median peer; over one year -36.5%.

How these numbers are made. Returns are close-to-close in local currency. Revenue growth and margins are trailing twelve months. Req g is the revenue growth that today's enterprise value requires for seven years at the company's own cost of capital; Delivered g is what it actually grew; the gap is the hurdle (honest precision about ±8 points, so read the ranking more than the decimal). No fair values, price targets or analyst ratings are shown, by design. Method and validation.